AndreaBozzo/ceres-open-data-index huggingface dataset:
Optimization of Aspergillus versicolor culture and aerosolization in a murine model of inhalational fungal exposure

Aspergillus versicolor is ubiquitous in the environment and is particularly abundant in damp indoor spaces. Exposure to Aspergillus species, as well as other environmental fungi, has been linked to adverse health outcomes including asthma, allergy, and even local or disseminated infection. However, the pulmonary immunological mechanisms associated with repeated exposure to A. versicolor have remained relatively uncharacterized. Here, A. versicolor was cultured and desiccated on rice, then placed in an acoustical generator system to achieve aerosolization. Mice were challenged with titrated doses of aerosolized conidia to examine deposition, lymphoproliferative properties, and then the immunotoxicological response to repeated inhalation exposures. The necessary dose to induce lymphoproliferation, but not infection-like pathology, was identified. Further, it was determined that the dose was able to initiate localized immune responses. The data presented in this study demonstrate an optimized and reproducible method for delivering A. versicolor conidia to rodents via nose-only inhalation. Additionally, the feasibility of a long-term repeated exposure study was established.  This experimental protocol can be used in future studies to investigate physiological effects of repeated pulmonary exposure to fungal conidia utilizing a practical and relevant mode of delivery. In total, these data constitute an important foundation for subsequent research in the field.
2011 CMHS Uniform Reporting System (URS) Output Tables for Federated States of Micronesia

Center for Mental Health Services (CMHS) Uniform Reporting System (URS) Output Tables for 2011. The Uniform Reporting System (URS) is a state and national reporting system collected annually to support the Community Mental Health Services Block Grant program. State Mental Health Authorities report on National Outcome Measures (NOMS), evidence based practices, and utilization measures providing an overview of state mental health delivery systems.
Compound 529160: 1-Hexanamine, mono-TMS

Chemical compound data from PubChem database. IUPAC Name: N-trimethylsilylhexan-1-amine. Molecular Formula: C9H23NSi. Molecular Weight: 173.37. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
4.16a Facility licensing, certification, or accreditation, by type of care offered: 2010. Number

This is a National Survey of Substance Abuse Treatment Services (N-SSATS) data table showing facility licensing, certification, or accreditation, by type of care offered in 2010. N-SSATS is designed to collect data on the location, characteristics, and use of alcohol and drug abuse treatment facilities and services throughout the 50 States, the District of Columbia, and other U.S. jurisdictions.
Compound 527349: 16,20,24-Trimethyl-dotriacontyl cyanide

Chemical compound data from PubChem database. IUPAC Name: 17,21,25-trimethyltritriacontanenitrile. Molecular Formula: C36H71N. Molecular Weight: 518.0. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Child Welfare Outcomes 2020: Report to Congress

This Report to Congress provides information on the performance of states on seven national outcome categories and also includes data on contextual factors and findings of analyses conducted across states.

Note: The PDF is best viewed in Chrome or Firefox. If using Internet Explorer (IE), please right click the link, save the file, and view it locally.

Appendix A: Adoption and Safe Families Act of 1997 (Pub. L. 105—89)

Appendix B: Child Welfare Outcomes Report: Outcomes and Measures

Appendix C: Caseworker Visits

Appendix D: Child Welfare Outcomes Report: Data Sources and Elements

Appendix E: Child Maltreatment 2020: Summary of Key Findings

Appendix F: The AFCARS Report 28: FY 2020 Estimates

Appendix G: Data-Quality Criteria

Metadata-only record linking to the original dataset. Open original dataset below.
Hospital Cost Report Edited Data: 2009

The Institutional Cost Report (ICR) is a uniform report completed by New York hospitals to report income, expenses, assets, liabilities, and statistics to the Department of Health (DOH). Under DOH regulations, (Part 86-1.2), Article 28 hospitals are required to file financial and statistical data with DOH annually. The data filed is part of the ICR and is received electronically through a secured network. This data is used to develop Medicaid rates, assist in the formulation of reimbursement methodologies, and analyze trends. The ICR is a comprehensive compilation of exhibits that have been modified over time that users should consider when using the ICR dataset. It is possible that data is updated subsequent to posting on this website; therefore the data could become obsolete. To get the details related to the exhibits and data elements, please refer to the blank ICR form, the ICR Table of Contents, the ICR Instructions and the Glossary of Terms, Acronyms, and Abbreviations which are in the Supporting Information section of this site. The data posted as edited contains desk edit adjustments by DOH personnel. In 2009, this information was not audited; however effective with the 2010 ICR, all ICRs will be audited by a Certified Public Accounting Firm annually.
Compound 525870: N,N-Dimethyl-N'-(3-bromophenyl)-isobutyramidine

Chemical compound data from PubChem database. IUPAC Name: N'-(3-bromophenyl)-N,N,2-trimethylpropanimidamide. Molecular Formula: C12H17BrN2. Molecular Weight: 269.18. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
2020 National Survey Of Substance Abuse Treatment Services (N-SSATS) State Profiles

These state profiles include data from facilities that reported to N-SSATS for the survey reference date March 31, 2020. The N-SSATS collects data on the location, characteristics, services offered, and number of clients (collected every other year) in treatment at alcohol and drug abuse treatment facilities (public and private) throughout the 50 states, the District of Columbia, U.S. territories, and other jurisdictions.
COVID-19 State Profile Report - Kansas

<b>After over two years of public reporting, the State Profile Report will no longer be produced and distributed after February 2023. The final release was on February 23, 2023. We want to thank everyone who contributed to the design, production, and review of this report and we hope that it provided insight into the data trends throughout the COVID-19 pandemic.
Data about COVID-19 will continue to be updated at <a href='https://covid.cdc.gov/covid-data-tracker/#datatracker-home' >CDC’s COVID Data Tracker</a>.
 </b>

<p>
The State Profile Report (SPR) is generated by the Data Strategy and Execution Workgroup in the Joint Coordination Cell, in collaboration with the White House. It is managed by an interagency team with representatives from multiple agencies and offices (including the United States Department of Health and Human Services (HHS), the Centers for Disease Control and Prevention, the HHS Assistant Secretary for Preparedness and Response, and the Indian Health Service). The SPR provides easily interpretable information on key indicators for each state, down to the county level.
 </p>

It is a weekly snapshot in time that:
<ul>
<li>Focuses on recent outcomes in the last seven days and changes relative to the month prior</li>
<li>Provides additional contextual information at the county level for each state, and includes national level information</li>
<li>Supports rapid visual interpretation of results with color thresholds</li>
</ul>
Early glandular neoplasia of the lung

Although bronchogenic carcinomas progress through a very well defined sequence of metaplasia, dysplasia and carcinoma in situ, very little is known about the early progression of glandular neoplasms of the lung. In particular, the early precursor lesion from which fully malignant adenocarcinomas arise has effectively eluded recognition, at least until recently. Several lines of evidence now implicate atypical adenomatous hyperplasia (AAH) as an initial morphologic stage in multistep lung tumorigenesis. Despite its small size, AAH can be appreciated at the light microscopic level and characterized at the molecular genetic level. Indeed, the genetic characterization of AAH promises to further our understanding of lung cancer development and might facilitate the design of novel strategies for early detection of lung cancer.
Patent AT-E400156-T1: [Translated] METHOD AND DEVICE FOR REASSOCIATING A BASE STATION CONTROLLER IN A WIRELESS COMMUNICATIONS SYSTEM

A method and apparatus for base station controller relocation in a wireless communication system are disclosed. The apparatus for relocating a serving base station controller according to the present invention comprises a switching function part and a signaling function part. The signaling function part executes a change through a connection procedure in response to a base station controller relocation request from a source base station controller. The switching function part creates a termination 3 (T3) for the target base station controller and performs simplex switching to the terminations to connect the termination 3 (T3) to a termination 2(T2) initially maintaining connection with the source base station controller, thereby relocating the target base station controller as a serving base station controller.
Compound 525044: 3',4'-Dichloropelargoanilide

Chemical compound data from PubChem database. IUPAC Name: N-(3,4-dichlorophenyl)nonanamide. Molecular Formula: C15H21Cl2NO. Molecular Weight: 302.2. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 528598: Butanedioic acid, 2,3-bis[(tert-butyldimethylsilyl)oxy]-, bis(tert-butyldimethylsilyl) ester

Chemical compound data from PubChem database. IUPAC Name: bis[tert-butyl(dimethyl)silyl] 2,3-bis[[tert-butyl(dimethyl)silyl]oxy]butanedioate. Molecular Formula: C28H62O6Si4. Molecular Weight: 607.1. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 529099: 4H-Pyrido[1,2-a]pyrimidin-4-one, 6,7,8,9-tetrahydro, 9-methyl

Chemical compound data from PubChem database. IUPAC Name: 9-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one. Molecular Formula: C9H12N2O. Molecular Weight: 164.2. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Child Care Licensing Study, 2008

The purpose of the 2008 Child Care Licensing Study is to report two aspects of child care licensing from 2008 for all 50 states and the District of Columbia (not including Idaho): (1) state child care licensing programs and policies and (2) child care center and family child care home licensing regulations. The study focuses on the processes and policies in each state related to staffing for the licensing program, monitoring facilities, and enforcement of licensing regulations. 

To collect information on states' licensing policies, including staffing, monitoring, and enforcement of licensing regulations, the National Association for Regulatory Administration (NARA) disseminated the 2008 NARA Child Care Licensing Program Survey to all state child care licensing agencies in May 2009. Responses were received from all states. The survey focused on the processes and policies in each state related to staffing for the licensing program, monitoring facilities, and enforcement of licensing regulations.  

<b>Units of Response: </b>State 

<b>Type of Data: </b>Survey 

<b>Tribal Data: </b>No 

<b>Periodicity: </b>One-time  

<b>Demographic Indicators: </b>Not Applicable

<b>SORN: </b> https://www.federalregister.gov/documents/2022/01/24/2022-01066/privacy-act-of-1974-system-of-records 

<b>Data Use Agreement: </b>Unavailable 

<b>Data Use Agreement Location: </b> Not Applicable 

<b>Granularity: </b>State 

<b>Spatial: </b>United States 

<b>Geocoding: </b>Unavailable
1 in 15 Veterans Had a Substance Use Disorder in the Past Year

This spotlight uses 2013 National Survey on Drug Use and Health to examine the percentage of U.S. military veterans that a substance use disorder.  Results are shown by the eras in which the veterans served, including post-9/11, August 1990 to August 2001, Mary 1975 to July 1990, the Vietnam era, and the pre-Vietnam era.
Patent AT-E401565-T1: [Translated] APPLICATION-SPECIFIC INTEGRATED CIRCUIT FOR FLUID ANALYSIS CONTROL

A circuit for determining characteristics of a fluid under-test is provided. The circuit includes analog-to-digital processing circuitry for interfacing with a sensor and host electronics. The analog-to-digital processing circuitry includes a frequency generator for providing stimulus to the sensor and receiving a response signal from the sensor. Conditioning circuitry for reducing analog signal offsets in the response signal and signal detection circuitry for identifying amplitude data of the response signal are provided. Further provided is analog-to-digital conversion circuitry for converting the detected amplitude data into digital form. Memory for holding calibration data and approximated fluid characteristics of the fluid under-test is included in the circuitry. The digital form of the response signal is processed in conjunction with the calibration data and approximated fluid characteristics to generate fluid characteristics of the actual fluid under-test. In other disclosed embodiments, the fluid characteristics can be obtained directly from a processed signal, which is differentially processed through a compensation device that is actively controlled by circuitry. In this alternative embodiment, curve fitting processing is not needed, as the processed signal itself provides the information that identifies the fluid characteristics for the fluid under-test.
Compound 529262: Farnesyl hexanoate

Chemical compound data from PubChem database. IUPAC Name: 3,7,11-trimethyldodeca-2,6,10-trienyl hexanoate. Molecular Formula: C21H36O2. Molecular Weight: 320.5. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
National Community Based Survey of Supports for Healthy Eating and Active Living  (CBS HEAL)

Community-Based Survey of Supports for Healthy Eating and Active Living (CBS HEAL) is a CDC survey of a nationally representative sample of U.S. municipalities to better understand existing community-level policies and practices that support healthy eating and active living. The survey collects information about policies such as nutrition standards, incentives for healthy food retail, bike/pedestrian-friendly design, and Complete Streets. About 2,000 municipalities respond to the survey. Participating municipalities receive a report that allows them to compare their policies and practices with other municipalities of similar geography, population size, and urban status.

The CBS HEAL survey was first administered in 2014 and was administered again in 2021. Data is provided in multiple formats for download including as a SAS file. A methods report and a SAS program for formatting the data are also provided.
Motor Vehicle Occupant Death Rate, by Age and Sex, 2012 & 2014, Region 8 - Denver

Rate of deaths by age/gender (per 100,000 population) for motor vehicle occupants killed in crashes, 2012 & 2014. 2012 Source: Fatality Analysis Reporting System (FARS). 2014 Source: National Highway Traffic Safety Administration's (NHTSA) Fatality Analysis Reporting System (FARS), 2014 Annual Report File Note: Blank cells indicate data are suppressed. Fatality rates based on fewer than 20 deaths are suppressed.
Compound 528696: Benzene, butyl-1,3-dimethyl-

Chemical compound data from PubChem database. IUPAC Name: 2-butyl-1,3-dimethylbenzene. Molecular Formula: C12H18. Molecular Weight: 162.27. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 525347: 2,2,6-Trimethyl-3,4-dithiaheptane

Chemical compound data from PubChem database. IUPAC Name: 1-(tert-butyldisulfanyl)-2-methylpropane. Molecular Formula: C8H18S2. Molecular Weight: 178.4. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
2021 General Payment Data

All general (non-research, non-ownership related) payments from the 2021 program year [January 1 – December 31, 2021]<p><strong>NOTE: </strong>This is a very large file and, depending on your network characteristics and software, may take a long time to download or fail to download. Additionally, the number of rows in the file may be larger than the maximum rows your version of <a href="https://support.microsoft.com/en-us/office/excel-specifications-and-limits-1672b34d-7043-467e-8e27-269d656771c3">Microsoft Excel</a> supports. If you can't download the file, we recommend engaging your IT support staff. If you are able to download the file but are unable to open it in MS Excel or get a message that the data has been truncated, we recommend trying alternative programs such as MS Access, Universal Viewer, Editpad or any other software your organization has available for large datasets.</p>
National Survey on Drug Use and Health (NSDUH-2010)

<p>The National Survey on Drug Use and Health (NSDUH) series (formerly titled National Household Survey on Drug Abuse) primarily measures the prevalence and correlates of drug use in the United States. The surveys are designed to provide quarterly, as well as annual, estimates. Information is provided on the use of illicit drugs, alcohol, and tobacco among members of United States households aged 12 and older. Questions included age at first use as well as lifetime, annual, and past-month usage for the following drug classes: marijuana, cocaine (and crack), hallucinogens, heroin, inhalants, alcohol, tobacco, and nonmedical use of prescription drugs, including pain relievers, tranquilizers, stimulants, and sedatives. The survey covered substance abuse treatment history and perceived need for treatment, and included questions from the Diagnostic and Statistical Manual (DSM) of Mental Disorders that allow diagnostic criteria to be applied. The survey included questions concerning treatment for both substance abuse and mental health-related disorders. Respondents were also asked about personal and family income sources and amounts, health care access and coverage, illegal activities and arrest record, problems resulting from the use of drugs, and needle-sharing. Questions introduced in previous administrations were retained in the 2010 survey, including questions asked only of respondents aged 12 to 17. These "youth experiences" items covered a variety of topics, such as neighborhood environment, illegal activities, drug use by friends, social support, extracurricular activities, exposure to substance abuse prevention and education programs, and perceived adult attitudes toward drug use and activities such as school work. Several measures focused on prevention-related themes in this section. Also retained were questions on mental health and access to care, perceived risk of using drugs, perceived availability of drugs, driving and personal behavior, and cigar smoking. Questions on the tobacco brand used most often were introduced with the 1999 survey. For the 2008 survey, adult mental health questions were added to measure symptoms of psychological distress in the worst period of distress that a person experienced in the past 30 days and suicidal ideation. In 2008, a split-sample design also was included to administer separate sets of questions (WHODAS vs. SDS) to assess impairment due to mental health problems. Beginning with the 2009 NSDUH, however, all of the adults in the sample received only the WHODAS questions. Background information includes sex, race, age, ethnicity, marital status, educational level, job status, veteran status, and current household composition. This study has 1 Data Set.</p>
Severe community-acquired meningitis

Community-acquired meningitis is associated with high morbidity and mortality. The epidemiology of community-acquired meningitis has changed over the past 15 years with the use of new vaccines and with the development of resistance to antibiotics. Bacterial meningitis would appear to be the most frequent by far, but most viral aetiologies are very often poorly recognized. The annual incidence of purulent community-acquired meningitis in France was estimated at 22 cases per million inhabitants in 1993. Age is a major risk factor in bacterial meningitis. The most affected group is children under 2 years of age, in whom the infection rate ranges from 10 to 110 cases per 100000 infants per year. Such cases must be considered as an absolute medical emergency. This review is limited to meningitis in immunocompetent patients.
Compound 527191: Zizanal

Chemical compound data from PubChem database. IUPAC Name: 7,7-dimethyl-6-methylidenetricyclo[6.2.1.01,5]undecane-2-carbaldehyde. Molecular Formula: C15H22O. Molecular Weight: 218.33. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Patent AT-E400432-T1: [Translated] METHOD FOR PRODUCING A POLYESTER TRAY PACKAGING WITH A MULTI-LAYER LID FILM CONTAINING A SEALING LAYER OF GLYCOL-MODIFIED COPOLYESTER

Chemical patent from PubChem database. Patent Number: AT-E400432-T1. Title: Crystalline Forms of Chemical Compounds. Filing Date: 1993-04-19. Inventors: Martinez, Carlos, Thompson, Emily. Abstract: The invention provides novel crystalline forms of chemical compounds, characterized by specific X-ray powder diffraction patterns and thermal properti... IPC Classifications: C07D, A61K, A61P. This patent covers 41 claims related to 3 chemical compounds. Useful for intellectual property research, prior art searches, and chemical innovation tracking.